Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
LB100 is a small molecule that inhibits PP2A activity, resulting in increased sensitivity of tumor cells to DNA damaging agents, including chemotherapy and radiotherapy (PMID: 25376608, PMID: 31935881, PMID: 30679389).
|DrugClasses||PP2A Inhibitor 2|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Cisplatin + LB-100||Cisplatin LB-100||1||0|
|Docetaxel + LB-100||Docetaxel LB-100||0||1|